Kmt2c mutations enhance HSC self-renewal capacity and convey a selective advantage after chemotherapy

Authors

Ran Chen, Washington University School of Medicine in St. Louis
Theresa Okeyo-Owuor, Washington University School of Medicine in St. Louis
Riddhi M Patel, Washington University School of Medicine in St. Louis
Emily B Casey, Washington University School of Medicine in St. Louis
Andrew S Cluster, Washington University School of Medicine in St. Louis
Wei Yang, Washington University School of Medicine in St. Louis
Jeffrey A Magee, Washington University School of Medicine in St. Louis

Journal

Cell Reports

Publication Date

2-16-2021

Volume

34

Issue

7

First Page

108751

Document Type

Open Access Publication

DOI

10.1016/j.celrep.2021.108751

Rights and Permissions

Chen R, Okeyo-Owuor T, Patel RM, Casey EB, Cluster AS, Yang W, Magee JA. Kmt2c mutations enhance HSC self-renewal capacity and convey a selective advantage after chemotherapy. Cell Rep. 2021 Feb 16;34(7):108751. doi: 10.1016/j.celrep.2021.108751. Copyright 2021 The Author(s). This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Recommended Citation

Chen, Ran; Okeyo-Owuor, Theresa; Patel, Riddhi M; Casey, Emily B; Cluster, Andrew S; Yang, Wei; and Magee, Jeffrey A, "Kmt2c mutations enhance HSC self-renewal capacity and convey a selective advantage after chemotherapy." Cell Reports. 34, 7. 108751 (2021).
https://digitalcommons.wustl.edu/open_access_pubs/11287